Di Lullo L - Search Results

1

Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer.

Recchia F, Nuzzo A, Lalli A, Lombardo M, Di Lullo L, Fabiani F, Fanini R, Venturoni L, Torchio P, Peretti G. Recchia F, et al. Among authors: di lullo l. Am J Clin Oncol. 1996 Jun;19(3):301-4. doi: 10.1097/00000421-199606000-00019. Am J Clin Oncol. 1996. PMID: 8638546 Clinical Trial.

2

Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.

Recchia F, Lococo A, Campisi C, Lalli A, Di Lullo L, De Filippis S, Vaccarili M, Zappalà A, Corrao G, Rea S. Recchia F, et al. Among authors: di lullo l. Am J Clin Oncol. 1999 Feb;22(1):57-61. doi: 10.1097/00000421-199902000-00014. Am J Clin Oncol. 1999. PMID: 10025382 Clinical Trial.

3

Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy.

Recchia F, Rea S, Nuzzo A, Lalli A, Di Lullo L, De Filippis S, Saggio G, Di Blasio A, Massa E, Mantovani G. Recchia F, et al. Among authors: di lullo l, di blasio a. Oncol Rep. 2003 Jan-Feb;10(1):65-9. Oncol Rep. 2003. PMID: 12469146 Clinical Trial.

4

Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.

Recchia F, Rea S, Nuzzo A, Lalli A, Di Lullo L, De Filippis S, Saggio G, Biondi E, Massa E, Mantovani G. Recchia F, et al. Among authors: di lullo l. Anticancer Res. 2004 May-Jun;24(3b):1935-40. Anticancer Res. 2004. PMID: 15274380 Free article. Clinical Trial.

5

Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer.

Recchia F, Nuzzo A, Lalli A, Di Lullo L, De Filippis S, Saggio G, Di Blasio A, Rea S. Recchia F, et al. Among authors: di lullo l, di blasio a. Anticancer Res. 2003 May-Jun;23(3C):2903-8. Anticancer Res. 2003. PMID: 12926132 Clinical Trial.

6

Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group.

Comella P, Biglietto M, Casaretti R, De Lucia L, Avallone A, Maiorino L, Di Lullo L, De Cataldis G, Rivellini F, Comella G. Comella P, et al. Among authors: di lullo l. Oncology. 2001;60(2):127-33. doi: 10.1159/000055309. Oncology. 2001. PMID: 11244327 Clinical Trial.

7

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.

Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; “FOLLOW-UP” Study Group. Natoli C, et al. PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014. PLoS One. 2014. PMID: 24714591 Free PMC article.

8

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.

9

Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer.

Morganti AG, Mignogna S, Deodato F, Massaccesi M, Cilla S, Calista F, Serafini G, Digesú C, Macchia G, Picardi V, Caravatta L, Di Lullo L, Giglio G, Sallustio G, Piermattei A, Cellini N, Valentini V. Morganti AG, et al. Among authors: di lullo l. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1073-80. doi: 10.1016/j.ijrobp.2009.12.020. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 20472342

10

Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study.

Morganti AG, Cellini F, Mignogna S, Padula GD, Caravatta L, Deodato F, Picardi V, Macchia G, Cilla S, Buwenge M, Di Lullo L, Gambacorta MA, Balducci M, Mattiucci GC, Autorino R, Valentini V. Morganti AG, et al. Among authors: di lullo l. Future Oncol. 2016 Mar;12(6):779-87. doi: 10.2217/fon.15.350. Epub 2016 Feb 1. Future Oncol. 2016. PMID: 26829128 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters